Literature DB >> 24781979

Studies on production and biological potential of prodigiosin by Serratia marcescens.

Rahul K Suryawanshi1, Chandrashekhar D Patil, Hemant P Borase, Bipinchandra K Salunke, Satish V Patil.   

Abstract

Efficacy of Serratia marcescens for pigment production and biological activity was investigated. Natural substrates like sweet potato, mahua flower extract (Madhuca latifolia L.), and sesam at different concentrations were taken. As a carbon source microorganism favored potato powder was followed by sesam and mannitol, and as nitrogen source casein hydrolysate was followed by yeast and malt extract. The effect of inorganic salts on pigment production was also studied. At final optimized composition of suitable carbon, nitrogen source, and trace materials and at suitable physiological conditions, prodigiosin production was 4.8 g L(-1). The isolated pigment showed antimicrobial activity against different pathogenic bacteria and fungi. Extracted pigment was characterized by spectroscopy, Fourier transform infrared (FTIR), and thin layer chromatography (TLC) which confirm production of biological compound prodigiosin. This study suggests that use of sweet potato powder and casein can be a potential alternative bioresource for commercial production of pigment prodigiosin.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24781979     DOI: 10.1007/s12010-014-0921-3

Source DB:  PubMed          Journal:  Appl Biochem Biotechnol        ISSN: 0273-2289            Impact factor:   2.926


  15 in total

1.  Optimization of physicochemical parameters influencing the production of prodigiosin from Serratia nematodiphila RL2 and exploring its antibacterial activity.

Authors:  Vijay Singh Gondil; Mohammad Asif; Tek Chand Bhalla
Journal:  3 Biotech       Date:  2017-09-20       Impact factor: 2.406

2.  Enhanced production of prodigiosin by Serratia marcescens UCP 1549 using agrosubstrates in solid-state fermentation.

Authors:  Renata Andreia Dos Santos; Dayana Montero Rodríguez; Lucas Albuquerque Rosendo da Silva; Sérgio Mendonça de Almeida; Galba Maria de Campos-Takaki; Marcos Antônio Barbosa de Lima
Journal:  Arch Microbiol       Date:  2021-05-30       Impact factor: 2.552

3.  The effectiveness of antimicrobial photodynamic therapy with prodigiosin against reference strains of Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa.

Authors:  Amin Derakhshanfar; Banafsheh Rastegari; Hossein Sharifi; Hossein Khajeh-Zadeh; Javad Moayedi
Journal:  Lasers Med Sci       Date:  2022-09-26       Impact factor: 2.555

Review 4.  Prodigiosin and its potential applications.

Authors:  N Darshan; H K Manonmani
Journal:  J Food Sci Technol       Date:  2015-01-24       Impact factor: 2.701

5.  Selective Cytotoxic Activity of Prodigiosin@halloysite Nanoformulation.

Authors:  Ivan Guryanov; Ekaterina Naumenko; Farida Akhatova; Giuseppe Lazzara; Giuseppe Cavallaro; Läysän Nigamatzyanova; Rawil Fakhrullin
Journal:  Front Bioeng Biotechnol       Date:  2020-05-26

6.  Biological Potential and Mechanism of Prodigiosin from Serratia marcescens Subsp. lawsoniana in Human Choriocarcinoma and Prostate Cancer Cell Lines.

Authors:  Dan Li; Jun Liu; Xin Wang; Di Kong; Wei Du; Hongbo Li; Chung-Yun Hse; Todd Shupe; Dongpo Zhou; Kai Zhao
Journal:  Int J Mol Sci       Date:  2018-11-04       Impact factor: 5.923

7.  Using prodigiosin against some gram-positive and gram-negative bacteria and Trypanosoma cruzi.

Authors:  Rocío Herráez; Anna Mur; Alexandra Merlos; Miguel Viñas; Teresa Vinuesa
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2019-06-03

8.  Targeted Delivery Prodigiosin to Choriocarcinoma by Peptide-Guided Dendrigraft Poly-l-lysines Nanoparticles.

Authors:  Kai Zhao; Dan Li; Guogang Cheng; Baozhen Zhang; Jinyu Han; Jie Chen; Baobei Wang; Mengxia Li; Tianxia Xiao; Jian Zhang; Dongpo Zhou; Zheng Jin; Xiujun Fan
Journal:  Int J Mol Sci       Date:  2019-11-01       Impact factor: 5.923

Review 9.  Production and Potential Applications of Bioconversion of Chitin and Protein-Containing Fishery Byproducts into Prodigiosin: A Review.

Authors:  San-Lang Wang; Van Bon Nguyen; Chien Thang Doan; Thi Ngoc Tran; Minh Trung Nguyen; Anh Dzung Nguyen
Journal:  Molecules       Date:  2020-06-13       Impact factor: 4.411

10.  Prodigiosin/PU-H71 as a novel potential combined therapy for triple negative breast cancer (TNBC): preclinical insights.

Authors:  Mohammed Moustapha Anwar; Manal Shalaby; Amira M Embaby; Hesham Saeed; Mona M Agwa; Ahmed Hussein
Journal:  Sci Rep       Date:  2020-09-07       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.